Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:06.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor platform/release change without altering the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:23.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:09.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T08:53:12.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T04:29:36.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is added, replacing earlier revisions. The funding-lapse notice and Revision v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T17:09:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.